Keiichi Okutomi

Title: Keiichi Okutomi: Innovator in Alzheimer’s Disease Research

Introduction

Keiichi Okutomi is a prominent inventor located in Tokushima, Japan, recognized for his contributions to the field of neurodegenerative disease research. With two patents to his name, Okutomi is at the forefront of developing innovative solutions to combat Alzheimer's disease.

Latest Patents

Okutomi's latest patents revolve around the Ly6H polypeptide and the Ly6H gene. Both inventions focus on a brain-specific gene that has significant utility in the treatment of Alzheimer's disease. The first patent presents a nucleotide sequence coding for the amino acid sequence shown in SEQ ID NO:1, along with various related elements such as an expression vector, a host cell comprising the expression vector, and a therapeutic composition for neurodegenerative diseases. Similarly, the second patent encompasses the same brain-specific gene, emphasizing its potential in treating conditions associated with Alzheimer's disease.

Career Highlights

Throughout his career, Keiichi Okutomi has worked with esteemed companies such as Otsuka Pharmaceutical Company, Limited and Osaka Pharmaceutical Co., Ltd. His work at these organizations has helped to further the understanding and development of therapeutic strategies for Alzheimer's and related diseases.

Collaborations

During his journey as an inventor, Okutomi has collaborated with notable peers in the industry, including Masato Horie and Yoshihiro Taniguchi. These collaborations have played a significant role in advancing his research and innovations.

Conclusion

Keiichi Okutomi stands as a significant figure in the realm of Alzheimer’s disease research, with innovative patents that offer hope for future treatments. His contributions through collaboration and career efforts at reputable pharmaceutical companies underscore his dedication to improving the lives of those affected by neurodegenerative diseases.